Product Description
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.Veterinary injection is the act of putting a liquid, especially a drug, into an animal's body using a needle (usually a hypodermic needle) and a syringe.
The Veterinary Injection market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Veterinary Injection market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Veterinary Injection Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Veterinary Injection market are:
Bayer
CAHIC
Ceva
MERIAL
Lilly
Novartis
Boehringer
Ringpu
Zoetis(Pfizer)
Lukang Pharma
Virbac
Vetoquinol
Most important types of Veterinary Injection products covered in this report are:
Antibacterials
Antiviral drugs
Most widely used downstream fields of Veterinary Injection market covered in this report are:
Poultry
Ruminants
Pigs
Pets
Other
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.